Natarajan, S.K., Ogilvy, C.S., Hopkins, L.N., Siddiqui, A.H. and Levy, E.I. (2010) Initial Experience with an Everolimus-Eluting, Second-Generation Drug-Eluting Stent for Treatment of Intracranial Atherosclerosis. Journal of NeuroInterventional Surgery, 2, 104-109.
http://dx.doi.org/10.1136/jnis.2009.001875

has been cited by the following article:

• TITLE: Intracranial Atherosclerosis: The Natural History and Management Strategies

  AUTHORS: Ossama Mansour, Martin Schumacher, Mohammad A. Farrag, Foad Abd-Allah

  KEYWORDS: Intracranial Atherosclerosis, Medical Therapy, Endovascular Treatment

  JOURNAL NAME: World Journal of Cardiovascular Diseases, Vol.4 No.7, June 12, 2014

  ABSTRACT: Intracranial atherosclerotic disease (ICAD) represents a major cause of stroke and transient ischemic attacks. The prevalence and natural course of ICAD are closely related to race and ethnicity. The best treatment for ICAD is a crucial issue; data from recent trials indicate that aggressive medical management and life style modifications are better than endovascular treatments for prevention of recurrent stroke in high-risk patients with ICAD. Endovascular treatment is still an option for subgroup of patients who are not responded to optimal medical therapy.